Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lynn

Showing results (141-150 of 240) with videos related to

Pageof 24
Sort By:
Urologic Oncology|July 16, 2023
Determining the association of rurality and cardiovascular disease among prostate cancer survivorsShaelee Nielsen, Brock O'Neil, Chun-Pin Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancerJennifer J Griggs, Mark R Somerfield, Holly Anderson, et al.
Journal of the National Cancer Institute|February 25, 2021
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase InhibitorsDawn L Hershman, Alfred I Neugut, Anna Moseley, et al.
Journal of Adolescent and Young Adult Oncology|April 18, 2024
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured InterviewsRobert Knoerl, Katherine Grandinetti, Liat Smener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline RecommendationsN Lynn Henry, Mark R Somerfield, Vandana G Abramson, et al.
JAMA Network Open|November 11, 2022
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical TrialDawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Pageof 24

Showing results (141-150 of 240) with videos related to

Sort By:
Pageof 24
Urologic Oncology|July 16, 2023
Determining the association of rurality and cardiovascular disease among prostate cancer survivorsShaelee Nielsen, Brock O'Neil, Chun-Pin Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancerJennifer J Griggs, Mark R Somerfield, Holly Anderson, et al.
Journal of the National Cancer Institute|February 25, 2021
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase InhibitorsDawn L Hershman, Alfred I Neugut, Anna Moseley, et al.
Journal of Adolescent and Young Adult Oncology|April 18, 2024
Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured InterviewsRobert Knoerl, Katherine Grandinetti, Liat Smener, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2016
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline RecommendationsN Lynn Henry, Mark R Somerfield, Vandana G Abramson, et al.
JAMA Network Open|November 11, 2022
Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical TrialDawn L Hershman, Joseph M Unger, Heather Greenlee, et al.
NPJ Breast Cancer|November 19, 2022
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30N Lynn Henry, Sungjin Kim, Ron D Hays, et al.
Journal of Clinical Pharmacology|December 17, 2011
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozoleLauren Nicole Bell, Anne Thi Phuong Nguyen, Lang Li, et al.
Cancer|May 8, 2014
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapyKelley M Kidwell, Steven E Harte, Daniel F Hayes, et al.
The Journal of Pain|January 28, 2014
Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancerN Lynn Henry, Anna Conlon, Kelley M Kidwell, et al.
Pageof 24